HEMERA 1, a phase 1 trial of carboxyhemoglobin oxygen delivery for revascularization in acute stroke

Join Italo Linfante (USA) and Rodrigo Rivera (Chile) as they discuss HEMERA 1, a phase 1 trial investigating carboxyhemoglobin oxygen delivery for revascularization in acute stroke. This innovative study aims to explore the potential benefits of using carboxyhemoglobin to enhance oxygen delivery to affected brain regions during an acute stroke, with the goal of improving revascularization and patient outcomes. Watch video.
This interview was filmed at Linnc Paris 2023 .

LECTURE

conference room and Live streaming 4:00:01 pm Carotid revascularization for symptomatic thrombus after failure of medical therapy

INTERVIEW

Ángel Chamorro interview - The CHOICE Randomized Clinical Trial

INTERVIEW

Marc Ribó interview - Direct to Angiography Suite Without Stopping for Computed Tomography Imaging for Patients With Acute Stroke

INTERVIEW

Download the LINNC INR Trials Book!

INTERVIEW

Wouter J. Schonewille and Francisco Mont'Alverne interview - BAO and BASICS trials